Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6884 (MIR6884) is a human regulatory non-coding RNA gene that produces a mature microRNA involved in post-transcriptional gene silencing by binding to complementary sequences in target mRNAs, leading to their translational inhibition or degradation[2]. miR-6884-5p, a functional product of this gene, acts as a tumor suppressor in gastric cancer cells by directly targeting S100A16, resulting in inhibition of cellular proliferation, invasion, and EMT. Expression levels of MIR6884-5p are inversely correlated with S100A16, marking its potential as a biomarker for cancer metastasis and progression. MicroRNAs like MIR6884 have no direct protein-coding function but exert significant influence on cellular phenotype by regulating multiple genes within complex post-transcriptional networks[1][2].
miRNA inhibition (potential therapeutic approaches include antagonists or mimics targeting microRNA function, but specific mechanisms depend on therapeutic context) Regulation of target mRNA stability and translation (by forming RNA-induced silencing complex, RISC)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6884 (MIR6884).